i

iFAST Diagnostics

3 employees

iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

Basic info

Industry

hospitals and health care

Sectors

Research and Development
Medtech
Health Care
Diagnostics
Medical Devices

Date founded

2022

Funding rounds raised

Total raised

$2.4M

from 1 investors over 1 rounds

i

iFAST Diagnostics raised $2.4M on January 1, 2023

Investors: Kadmos Capital Ltd

FAQ